Cargando…

Monogenic autoinflammatory diseases in adults – a challenge to rheumatologic practice at the onset of the Polish national programme of interleukin 1 inhibitor treatment

Monogenic autoinflammatory diseases (AIDs, formerly known as hereditary periodic fever syndromes) cover a spectrum of diseases which lead to chronic or recurrent inflammation caused by activation of the innate immune system. The most common monogenic AID is familial Mediterranean fever. Monogenic au...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milchert, Marcin, Makowska, Joanna, Brzezińska, Olga, Brzosko, Marek, Więsik-Szewczyk, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2019
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091486/ https://www.ncbi.nlm.nih.gov/pubmed/32226166 http://dx.doi.org/10.5114/reum.2019.91298

Ejemplares similares

Interleukin 1 inhibitors in monogenic autoinflammatory diseases – one size does not fit all
por: Więsik-Szewczyk, Ewa
Publicado: (2021)

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
por: Gaggiano, Carla, et al.
Publicado: (2022)

Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey
por: Gattorno, M, et al.
Publicado: (2008)

Coronavirus disease 2019 vaccination uptake and hesitancy among Polish patients with inborn errors of immunity, autoinflammatory syndromes, and rheumatic diseases: A multicenter survey
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2022)

Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases
por: Gaggiano, Carla, et al.
Publicado: (2019)

VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases
por: Vitale, Antonio, et al.
Publicado: (2023)

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions
por: Hernández-Rodríguez, José, et al.
Publicado: (2023)

Determination of antibodies in everyday rheumatological practice
por: Napiórkowska-Baran, Katarzyna, et al.
Publicado: (2019)

Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient
por: Milchert, Marcin, et al.
Publicado: (2017)

Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica
por: Milchert, Marcin, et al.
Publicado: (2020)

The expanding spectrum of rare monogenic autoinflammatory diseases
por: Touitou, Isabelle, et al.
Publicado: (2013)

Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease
por: Beck, David B., et al.
Publicado: (2019)

Dermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases
por: Figueras-Nart, Ignasi, et al.
Publicado: (2019)

Shorter Diagnostic Delay in Polish Adult Patients With Common Variable Immunodeficiency and Symptom Onset After 1999
por: Ziętkiewicz, Marcin, et al.
Publicado: (2020)

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
por: Bettiol, Alessandra, et al.
Publicado: (2019)

The attitude of Polish rheumatology patients towards telemedicine in the age of the COVID-19 pandemic
por: Opinc, Aleksandra, et al.
Publicado: (2020)

The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders
por: Moghaddas, Fiona, et al.
Publicado: (2018)

Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives
por: Di Donato, Giulia, et al.
Publicado: (2021)

Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease
por: Fischer, Katarzyna, et al.
Publicado: (2017)

Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
por: Kucharz, Eugeniusz J., et al.
Publicado: (2018)

Intima-media thickness cut-off values depicting “halo sign” and potential confounder analysis for the best diagnosis of large vessel giant cell arteritis by ultrasonography
por: Milchert, Marcin, et al.
Publicado: (2022)

Hearing Loss as the Main Clinical Presentation in NLRP3-Associated Autoinflammatory Disease
por: Oziębło, Dominika, et al.
Publicado: (2022)

Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders
por: Vitale, Antonio, et al.
Publicado: (2013)

Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood
por: Welzel, Tatjana, et al.
Publicado: (2021)

Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?
por: Manzo, Ciro, et al.
Publicado: (2020)

Biological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety
por: Pelagatti, Maria A, et al.
Publicado: (2014)

Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues
por: Caso, Francesco, et al.
Publicado: (2013)

Altered cytokine pattern and inflammatory pathways in monogenic and complex autoinflammatory diseases
por: Galozzi, P, et al.
Publicado: (2015)

A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases
por: Galozzi, Paola, et al.
Publicado: (2022)

Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations
por: Martorana, Davide, et al.
Publicado: (2017)

The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency
por: Kendall, Jennifer Lee, et al.
Publicado: (2020)

Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study
por: Opinc, Aleksandra, et al.
Publicado: (2020)

Monogenic and multifactorial autoinflammatory diseases: Clinical and laboratory characterization in a pediatric Saudi population
por: Al-Mayouf, S, et al.
Publicado: (2015)

Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review
por: Alsharief, Alaa N., et al.
Publicado: (2020)

Interferon in systemic lupus erythematosus—A halfway between monogenic autoinflammatory and autoimmune disease
por: Saulescu, Ioana, et al.
Publicado: (2022)

Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort
por: Hentgen, Véronique, et al.
Publicado: (2021)

Auditory and Vestibular Characteristics of NLRP3 Inflammasome Related Autoinflammatory Disorders: Monogenic Hearing Loss Can Be Improved by Anti-interleukin-1 Therapy
por: Nakanishi, Hiroshi, et al.
Publicado: (2022)

Biosimilar switching – current state of knowledge
por: Wiland, Piotr, et al.
Publicado: (2018)

Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity
por: Mielnik, Pawel, et al.
Publicado: (2010)

COVID-19 Pandemic and Patients with Rare Inherited Metabolic Disorders and Rare Autoinflammatory Diseases—Organizational Challenges from the Point of View of Healthcare Providers
por: Tobór-Świętek, Ewa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oapd0ilmlqpc1rk9chh1mh570f